BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
-13.27%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$676M
AUM Growth
+$676M
(-20%)
Cap. Flow
+$17.7M
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
90.65%
Holding
26
New
–
Increased
2
Reduced
2
Closed
2
Top Buys
| 1 |
Solid Biosciences
SLDB
|
$14.3M |
| 2 |
Savara
SVRA
|
$8.41M |
Top Sells
| 1 |
Olema Pharmaceuticals
OLMA
|
$2.35M |
| 2 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$1.44M |
| 3 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$632K |
| 4 |
Nautilus Biotechnolgy
NAUT
|
$591K |
Sector Composition
| 1 | Healthcare | 99.87% |